Find your path to Bill
317 people in our graph share verified history with Bill — schools, employers, funds. One of them is your warm intro.
Ankit GuptaunlockedBill: together at Ginkgo Bioworks (2024–2025)
Bill: together at Bellicum Pharmaceuticals, Inc.
×2Bill: together at AbbVie
×3Bill: together at Ginkgo Bioworks
About
Dr. Bill Grossman is Interim Chief Medical Officer at enGene and serves on the boards of Day One Biopharmaceuticals, enGene Inc., and Designing Dreams USA, along with advisory roles at Ginkgo Bioworks, Bolt Therapeutics, Noetik, and LTZ Therapeutics. His prior industry roles include Senior Vice President and Therapeutic Area Head of Oncology at Gilead, Chief Medical Officer at Arcus Biosciences and Bellicum Pharmaceuticals, and Global Group Medical Director for Cancer Immunotherapy at Genentech, with earlier positions at AbbVie, Merck & Co., Baxter Healthcare, and Biothera. He holds M.D. and Ph.D. (Immunology) degrees from Washington University School of Medicine, where he also completed advanced medical and research training
Co-founder, Strategic Advisor at Oncko
Intro paths
→
In turn, Bill can intro founders to Oncko's investors below.
Oncko's investors · 3
Co-founders at Oncko
AD
Atray DixitCo-founder, CEO
Experience
- enGeneInterim CMOcurrent2026 — present
- enGeneMember Board of Directorscurrent2025 — present
- LTZ TherapeuticsInterim CMOcurrent2026 — present
- LTZ TherapeuticsMember of the Board of Advisorscurrent2025 — present
- Grossman Biotech & Pharma Consulting, LLCFoundercurrent2019 — present
- NOETIKMember, Scientific Advisory Boardcurrent2025 — present
- Hexagon BioConsulting CMOcurrent2024 — present
- Coast-to-Coast BioConsultantsCo-Foundercurrent2024 — present
- OnckoStrategic Advisorcurrent2026 — present
- OnckoCo-Foundercurrent2024 — present
- Bolt Biotherapeutics, Inc.Member, Development Advisory Boardcurrent2025 — present
- Designing Dreams USAMember Board of Directorscurrent2025 — present
- Ginkgo Bioworks, Inc.Advisory Board Member2024 — 2026
- Day One Biopharmaceuticals (Acquired by Servier)Member Board of Directors2024 — 2026
- Gilead SciencesSVP - Oncology Clinical Development, Therapeutic Area Head2021 — 2024Foster City, California, United States
- BryoLogyxOncology Advisory Board2021 — 2024
- BryoLogyxMember Board Of Directors2019 — 2021California
- Tizona Therapeutics, Inc.Member Board Of Directors2021 — 2023
- Pionyr ImmunotherapeuticsMember Board Of Directors2021 — 2023
- Arcus BiosciencesChief Medical Officer2019 — 2021Hayward, California
- Bellicum Pharmaceuticals, Inc.SVP, Chief Medical Officer2018 — 2019South San Francisco
- GenentechGroup Medical Director, Cancer Immunotherapy - Global Product Development Oncology2015 — 2018
- AbbVieTherapeutic Area Lead, Oncology - Global Pharmaceutical R&D/Global Medical Affairs2013 — 2015North Chicago
- BiotheraSenior Vice President, Research & Development2011 — 2013
Skills & more
Hematology56Immunology95Oncology99Clinical5Transplantation3Pediatrics3Clinical Development36Infectious Diseases10Clinical Research70Life Sciences16Cancer19Biotechnology22
+9 more
Clinical TrialsDiagnosticsResearchScienceMolecular BiologyHealthcareR&DTranslational MedicineMedicineFrom Bill's professional profile.
Frequently asked questions
- Who is Bill Grossman?
- Dr. Bill Grossman is Interim Chief Medical Officer at enGene and serves on the boards of Day One Biopharmaceuticals, enGene Inc., and Designing Dreams USA, along with advisory roles at Ginkgo Bioworks, Bolt Therapeutics, Noetik, and LTZ Therapeutics. His prior industry roles include Senior Vice President and Therapeutic Area Head of Oncology at Gilead, Chief Medical Officer at Arcus Biosciences and Bellicum Pharmaceuticals, and Global Group Medical Director for Cancer Immunotherapy at Genentech, with earlier positions at AbbVie, Merck & Co., Baxter Healthcare, and Biothera. He holds M.D. and Ph.D. (Immunology) degrees from Washington University School of Medicine, where he also completed advanced medical and research training
- Where does Bill Grossman work?
- Bill Grossman is Co-founder, Strategic Advisor of Oncko.
- What companies did Bill Grossman found?
- Bill Grossman founded Oncko.
- Where did Bill Grossman go to school?
- Bill Grossman studied at Washington University School of Medicine in St. Louis (MD, PhD); St. Louis Children's Hospital (Fellowship - Hematology/Oncology/Transplantation); St. Louis Children's Hospital (Internship/Residency).
Founder mafias
University of St. Thomas mafia19
Also came through, then founded or led a company.
Mike ReinhartMBAFounded Quisitive +1Rob PhythianBA- Business AdministrationFounded SportsHub Games Network +1Bruno KurticBAFounded Bedrockdata +1Patrick O'ShaughnessyFounded ColossusMatt MeentsBBAFounded YardstikTim HerbertMaster of Business Administration (MBA)Founded Inspire Medical
+ 12 more
Ginkgo Bioworks mafia16
Also came through, then founded or led a company.
Ankit GuptaHead of AIFounded Reverie LabsDavid BeyerInvestorFounded ChartioReshma ShettyCo-founderFounded Ginkgo BioworksCharlie PintoInvestorFounded SlidePayMichelle DetwilerBoard ObserverFounded BiospringNick RancisDirector, Commercial OperationsFounded Clear Comfort Water
+ 9 more
Washington University School of Medicine in St. Louis mafia14
Also came through, then founded or led a company.
Ansuman SatpathyDoctor of Philosophy (Ph.D.)Founded Santa Ana +4Eric LeuthardtChief Resident & Resident PhysicianFounded Inner Cosmos +3Reid HuberPhDFounded MOMA Therapeutics +2Nicholas GoldnerDoctor of PhilosophyFounded Viosera +1Corey M. McCannMD/PhDFounded T.Rx Capital +1Ben ScruggsPhDFounded Altis Biosystems
+ 7 more
AbbVie mafia13
Also came through, then founded or led a company.
Evan MurphySenior Software EngineerFounded Zitara +1Matthew RastovacSoftware Engineering InternFounded Atmos +1Nick GasbarroGovernment Affairs InternFounded CognizantRoss LeimbergDirectorFounded Cantai TherapeuticsDonmienne LeungDirector II, Head of AbbVie Ventures EuropeFounded ThirtyFiveBio LimitedJim Sullivan, Ph.D.Vice President Global DiscoveryFounded Vanquabio
+ 6 more
Noetik mafia3
Also came through, then founded or led a company.
Same school
Also attended Washington University School of Medicine in St. Louis27
Reid HuberPartner at Third Rock VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresBen ScruggsPartner at Hatteras Venture PartnersDaguang WangManaging Director at Yonjin Venture LLCDave VreelandSenior Managing Partner at Caduceus Capital Partners
+ 21 more
Also attended University of St. Thomas76
Kayla HinderscheidHead of Network Development at Menlo VenturesRyan KruizengaGeneral Partner at Arthur VenturesDerek BuschowEntrepreneur in Residence at Arthur VenturesKyle FrederickDirector at Arthur VenturesChloe GinkelAssociate at Arthur VenturesMegan BanieckeAssociate at Homegrown Capital
+ 70 more
